Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area

Autor: Benoît Saint-Mleux, Barbara E. Jones, Laurence Bayer, Emmanuel Eggermann, Danièle Machard, Arnaud Bisetti, Michel Muhlethaler, Mauro Serafin
Jazyk: angličtina
Rok vydání: 2004
Předmět:
Nicotinic Agonists/ pharmacology
Potassium Channels
Patch-Clamp Techniques
Receptors
Nicotinic

Norepinephrine/ metabolism
Sleep/physiology
Norepinephrine
chemistry.chemical_compound
Preoptic Area/anatomy & histology/cytology/ physiology
Muscarinic acetylcholine receptor
Nicotinic Agonists
Cells
Cultured

Neurons
Chemistry
General Neuroscience
Drug Synergism
Neurons/drug effects/ physiology
Muscarinic Antagonists/pharmacology
Receptors
Muscarinic

Potassium Channels/metabolism
Presynaptic Terminals/metabolism
Nicotinic agonist
Receptors
Nicotinic/metabolism

Epibatidine
Brief Communications
Acetylcholine
medicine.drug
Agonist
medicine.drug_class
Presynaptic Terminals
Muscarinic Antagonists
Muscarinic Agonists
Inhibitory postsynaptic potential
Receptors
Muscarinic/metabolism

medicine
Animals
Acetylcholine/ pharmacology
Muscarinic Agonists/pharmacology
Methyllycaconitine
Electric Conductivity
Neural Inhibition
Preoptic Area
ddc:616.8
Rats
nervous system
Cholinergic
Sleep
Neuroscience
Zdroj: Journal of Neuroscience, Vol. 24, No 1 (2004) pp. 63-67
ISSN: 0270-6474
Popis: According to multiple lines of evidence, neurons in the ventrolateral preoptic area (VLPO) that contain GABA promote sleep by inhibiting neurons of the arousal systems. Reciprocally, transmitters used by these systems, including acetylcholine (ACh) and noradrenaline (NA), exert an inhibitory action on the VLPO neurons. Because nicotine, an agonist of ACh, acts as a potent stimulant, we queried whether it might participate in the cholinergic inhibition of these sleep-promoting cells. Indeed, we found that ACh inhibits the VLPO neurons through a nicotinic, as well as a muscarinic, action. As evident in the presence of atropine, the non-muscarinic component was mimicked by epibatidine, a nonselective nicotinic ACh receptor (nAChR) agonist and was blocked by dihydro-β-erythroidine, a nonselective nAChR antagonist. It was not, however, blocked by methyllycaconitine, a selective antagonist of the α7 subtype, indicating that the action was mediated by non-α7 nAChRs. The nicotinic inhibition was attributed to a presynaptic facilitation of NA release because it persisted in the presence of tetrodotoxin and was blocked by yohimbine and RS 79948, which are both selective antagonists of α2 adrenergic receptors. Sleep-promoting VLPO neurons are thus dually inhibited by ACh through a muscarinic postsynaptic action and a nicotinic presynaptic action on noradrenergic terminals. Such dual complementary actions allow ACh and nicotine to enhance wakefulness by inhibiting sleep-promoting systems while facilitating other wake-promoting systems.
Databáze: OpenAIRE